If you are interested in finding out more about the Nuritas discovery platform, please see our new feature with the Nature Research Group, where we discuss how we can move from Target/Disease area to patentable peptides within 12 months.
For more information, please contact:
Chantelle Kiernan, Director of Life Sciences
or
Paul Rohricht, Chief Business Officer – Pharma
Email: [email protected]
